Hepion Pharmaceuticals, Inc. (HEPA) NASDAQ
0.06
+0.002(+3.33%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.06
+0.002(+3.33%)
Currency In USD
| Market Cap | 564,562.5 |
| Enterprise Value | -1.21M |
| P/E Ratio | -0.07 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.22 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.7 |
| Return On Equity | -2.42 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -4.16M |
| Net Income | -8.28M |
| Diluted EPS | -0.88 |
| Total Cash | 1.83M |
| Total Cash/Share | 0.19 |
| Total Debt | 54,066 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 10.25 |
| Book Value Per Share | 0.28 |
| 52-Week Change | -94.61 |
| 52-Week High | 1.15 |
| 52-Week Low | 0.03 |
| Moving Average 50 Days | 0.05 |
| Moving Average 200 Days | 0.06 |
| Average Volume | 15,693 |
| Shares Outstanding | 11.62M |
| % Held by Institutions | 0.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | March 18, 2025 |